Literature DB >> 18192120

Encouraging results of low-dose etoposide in the treatment of early-onset hemophagocytic syndrome following allogeneic hematopoietic stem cell transplantation.

Maho Koyama, Akihisa Sawada, Masahiro Yasui, Masami Inoue, Keisei Kawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18192120     DOI: 10.1007/bf02984009

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  7 in total

Review 1.  Graft failure due to hemophagocytic syndrome after autologous peripheral blood stem cell transplantation.

Authors:  K Fukuno; H Tsurumi; T Yamada; M Oyama; H Moriwaki
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

2.  Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

Authors:  S Imashuku; K Kuriyama; T Teramura; E Ishii; N Kinugawa; M Kato; M Sako; S Hibi
Journal:  J Clin Oncol       Date:  2001-05-15       Impact factor: 44.544

3.  Adenovirus-related hemophagocytic syndrome after bone marrow transplantation.

Authors:  J Levy; R A Wodell; C S August; E Bayever
Journal:  Bone Marrow Transplant       Date:  1990-11       Impact factor: 5.483

4.  Fulminant, CMV-associated, haemophagocytic syndrome following unrelated bone marrow transplantation.

Authors:  M Sato; T Matsushima; S Takada; N Hatsumi; K Kim; M Sakuraya; T Saito; J Tamura; M Karasawa; H Murakami; T Naruse
Journal:  Bone Marrow Transplant       Date:  1998-12       Impact factor: 5.483

5.  Hemophagocytic syndrome: a rare complication of allogeneic nonmyeloablative hematopoietic stem cell transplantation.

Authors:  Y Abe; I Choi; K Hara; T Matsushima; J Nishimura; S Inaba; H Nawata; K Muta
Journal:  Bone Marrow Transplant       Date:  2002-05       Impact factor: 5.483

6.  Early onset of hemophagocytic syndrome following allogeneic bone marrow transplantation.

Authors:  J Ishikawa; T Maeda; T Miyazaki; N Manabe; S Honda; T Nishiura; Y Tomiyama; Y Matsuzawa
Journal:  Int J Hematol       Date:  2000-08       Impact factor: 2.490

7.  Nationwide survey of hemophagocytic lymphohistiocytosis in Japan.

Authors:  Eiichi Ishii; Shouichi Ohga; Shinsaku Imashuku; Masaki Yasukawa; Hiroyuki Tsuda; Ikuo Miura; Ken Yamamoto; Hisanori Horiuchi; Kenzo Takada; Koichi Ohshima; Shigeo Nakamura; Naoko Kinukawa; Kazuo Oshimi; Keisei Kawa
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

  7 in total
  6 in total

1.  Successful treatment with combined chemotherapy of two adult cases of hemophagocytic lymphohistiocytosis in recipients of umbilical cord blood cell transplantation.

Authors:  Akiko Fukunaga; Fumiaki Nakamura; Noriyoshi Yoshinaga; Shojiro Inano; Wataru Maruyama; Hirokazu Hirata; Nobuyoshi Arima
Journal:  Int J Hematol       Date:  2011-03-08       Impact factor: 2.490

2.  Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation: macrophage-targeted steroid therapy.

Authors:  Satoshi Nishiwaki; Takayuki Nakayama; Makoto Murata; Tetsuya Nishida; Kyoko Sugimoto; Shigeki Saito; Tomonori Kato; Hiroki Mizuno; Nobuhiko Imahashi; Aika Seto; Yukiyasu Ozawa; Tatsunori Goto; Daisuke Koyama; Emi Yokohata; Naomi Kubota; Sonoko Kamoshita; Koichi Miyamura; Kimikazu Matsumoto; Masafumi Ito; Tomoki Naoe
Journal:  Int J Hematol       Date:  2012-02-15       Impact factor: 2.490

3.  The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis.

Authors:  Bernd Hartz; Rebecca Marsh; Kanchan Rao; Jan-Inge Henter; Michael Jordan; Lisa Filipovich; Peter Bader; Rita Beier; Birgit Burkhardt; Roland Meisel; Ansgar Schulz; Beate Winkler; Michael H Albert; Johann Greil; Gülsün Karasu; Wilhelm Woessmann; Selim Corbacioglu; Bernd Gruhn; Wolfgang Holter; Jörn-Sven Kühl; Peter Lang; Markus G Seidel; Paul Veys; Alexandra Löfstedt; Sandra Ammann; Stephan Ehl; Gritta Janka; Ingo Müller; Kai Lehmberg
Journal:  Blood       Date:  2016-04-20       Impact factor: 22.113

4.  Etoposide-containing conditioning regimen reduces the occurrence of hemophagocytic lymphohistiocytosis after SCT.

Authors:  R Kobayashi; J Tanaka; S Hashino; S Ota; Y Torimoto; Y Kakinoki; S Yamamoto; M Kurosawa; N Hatakeyama; Y Haseyama; H Sakai; K Sato; T Fukuhara
Journal:  Bone Marrow Transplant       Date:  2013-09-16       Impact factor: 5.483

Review 5.  Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: recent advances and controversies.

Authors:  Jong Jin Seo
Journal:  Blood Res       Date:  2015-09-22

6.  Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19.

Authors:  Akiyoshi Takami
Journal:  Int J Hematol       Date:  2020-05-12       Impact factor: 2.490

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.